← Back to Search

Spinal Cord Stimulation

Spinal Cord Stimulation vs. Medical Management for Lower Back Pain

N/A
Waitlist Available
Led By James Yue, MD
Research Sponsored by Abbott Medical Devices
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing BurstDR SCS, a therapy that uses electrical pulses to reduce pain by stimulating the spinal cord. It targets patients with chronic low back pain who haven't found relief from other treatments and can't undergo surgery. The electrical pulses help block pain signals from reaching the brain. BurstDR SCS is a new type of stimulation that has shown better results compared to older methods in treating chronic pain.

Who is the study for?
This trial is for adults over 18 with chronic low back pain lasting at least 6 months, which hasn't improved after standard treatments and isn't suitable for surgery. Participants should have a pain score of ≥6 and disability index of ≥30%, be eligible for spinal cord stimulation, and not have had previous spine surgeries or conditions that could explain their pain.
What is being tested?
The study compares BurstDR spinal cord stimulation to conventional medical management in improving pain and physical function in patients with chronic axial low back pain with neuropathic characteristics who are not candidates for lumbar spine surgery.
What are the potential side effects?
Potential side effects from spinal cord stimulation can include discomfort at the implant site, unwanted changes in stimulation, nerve injury, and infection. Conventional medical management side effects depend on the specific treatments used but may include medication-related issues like stomach upset or drowsiness.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
The Difference in Responders Between Both Groups
Secondary study objectives
Measure of Composite Responder Rate
Numerical Rating Scale (NRS) Relative Change From Baseline to 6 Months
Oswestry Disability Index (ODI) Change From Baseline to 6 Months
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Spinal Cord Stimulation (SCS)Active Control1 Intervention
An SCS Trial period followed by SCS Implantation with the Abbott Proclaim XR Implantable Pulse Generator
Group II: Conventional Medical Management (CMM)Active Control1 Intervention
CMM consists of an array of therapies including, but not limited to structured physical therapy, medications, injections, and complementary and alternative medicine (e.g. acupuncture, massage therapy)

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
BurstDR Dorsal Column Stimulation (DCS) and other neuromodulation techniques for Chronic Low Back Pain (CLBP) work by altering pain signal transmission at the spinal cord and brain levels. DCS uses specific waveforms and temporal patterns to inhibit pain pathways and activate pain-inhibitory mechanisms, providing relief by reducing the perception of pain. This is crucial for CLBP patients as it offers an alternative when conventional medical management fails, targeting the pain at its source and potentially improving quality of life. Other interventional therapies, such as epidural steroid injections and nerve blocks, aim to reduce inflammation and interrupt pain signals, offering short-term relief and complementing rehabilitation and pharmacotherapy.
The effect of dorsal column stimulation on the nociceptive response of dorsal horn cells and its relevance for pain suppression.Mechanism of Action in Burst Spinal Cord Stimulation: Review and Recent Advances.

Find a Location

Who is running the clinical trial?

Abbott Medical DevicesLead Sponsor
650 Previous Clinical Trials
416,073 Total Patients Enrolled
James Yue, MDPrincipal Investigator
1 Previous Clinical Trials
15 Total Patients Enrolled

Media Library

Spinal Cord Stimulation (Spinal Cord Stimulation) Clinical Trial Eligibility Overview. Trial Name: NCT04479787 — N/A
Chronic Low Back Pain Research Study Groups: Spinal Cord Stimulation (SCS), Conventional Medical Management (CMM)
Chronic Low Back Pain Clinical Trial 2023: Spinal Cord Stimulation Highlights & Side Effects. Trial Name: NCT04479787 — N/A
Spinal Cord Stimulation (Spinal Cord Stimulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04479787 — N/A
Chronic Low Back Pain Patient Testimony for trial: Trial Name: NCT04479787 — N/A
~51 spots leftby Nov 2025